WO2011009797A3 - Plasmaadaptierte und balancierte gelatinelösung - Google Patents
Plasmaadaptierte und balancierte gelatinelösung Download PDFInfo
- Publication number
- WO2011009797A3 WO2011009797A3 PCT/EP2010/060210 EP2010060210W WO2011009797A3 WO 2011009797 A3 WO2011009797 A3 WO 2011009797A3 EP 2010060210 W EP2010060210 W EP 2010060210W WO 2011009797 A3 WO2011009797 A3 WO 2011009797A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- balanced
- plasma
- gelatin solution
- pharmaceutical preparation
- gelatin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010800330764A CN102470147A (zh) | 2009-07-20 | 2010-07-15 | 适用于血浆的平衡明胶溶液 |
EP10734480A EP2456446A2 (de) | 2009-07-20 | 2010-07-15 | Plasmaadaptierte und balancierte gelatinelösung |
RU2012105925/15A RU2012105925A (ru) | 2009-07-20 | 2010-07-15 | Адаптированный к плазме сбалансированный раствор желатина |
BR112012001229A BR112012001229A2 (pt) | 2009-07-20 | 2010-07-15 | formulação farmacêutica aquosa, uso da formulação farmacêutica aquosa |
MX2012000957A MX2012000957A (es) | 2009-07-20 | 2010-07-15 | Solucion de gelatina adaptada y equilibrada al plasma. |
IN419DEN2012 IN2012DN00419A (de) | 2009-07-20 | 2012-01-16 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009034132A DE102009034132A1 (de) | 2009-07-20 | 2009-07-20 | Plasmaadaptierte und balancierte Gelatinelösung |
DE102009034132.3 | 2009-07-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011009797A2 WO2011009797A2 (de) | 2011-01-27 |
WO2011009797A3 true WO2011009797A3 (de) | 2011-08-25 |
Family
ID=43334706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/060210 WO2011009797A2 (de) | 2009-07-20 | 2010-07-15 | Plasmaadaptierte und balancierte gelatinelösung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2456446A2 (de) |
KR (1) | KR20120046160A (de) |
CN (1) | CN102470147A (de) |
BR (1) | BR112012001229A2 (de) |
DE (2) | DE102009034132A1 (de) |
IN (1) | IN2012DN00419A (de) |
MX (1) | MX2012000957A (de) |
RU (1) | RU2012105925A (de) |
WO (1) | WO2011009797A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2651717B1 (es) * | 2016-07-26 | 2018-11-16 | Lara OLLER DUQUE | Solución acuosa cristaloide isotónica |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1313164A (en) * | 1969-04-28 | 1973-04-11 | Knox Gelatine Inc | Blood plasma substitute |
EP0223906A2 (de) * | 1982-10-29 | 1987-06-03 | Synthetic Blood Corporation | Gelatinbasierter vollständiger Blutersatz und dessen Herstellungsverfahren |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1238675A1 (de) | 2001-03-06 | 2002-09-11 | Fuji Photo Film B.V. | Rekombinante gelatineartige Proteine zur Verwendung als Plasmaexpander |
-
2009
- 2009-07-20 DE DE102009034132A patent/DE102009034132A1/de not_active Withdrawn
-
2010
- 2010-07-15 WO PCT/EP2010/060210 patent/WO2011009797A2/de active Application Filing
- 2010-07-15 EP EP10734480A patent/EP2456446A2/de not_active Withdrawn
- 2010-07-15 CN CN2010800330764A patent/CN102470147A/zh active Pending
- 2010-07-15 KR KR1020127000796A patent/KR20120046160A/ko not_active Application Discontinuation
- 2010-07-15 DE DE202010018349.9U patent/DE202010018349U1/de not_active Expired - Lifetime
- 2010-07-15 MX MX2012000957A patent/MX2012000957A/es not_active Application Discontinuation
- 2010-07-15 BR BR112012001229A patent/BR112012001229A2/pt not_active IP Right Cessation
- 2010-07-15 RU RU2012105925/15A patent/RU2012105925A/ru unknown
-
2012
- 2012-01-16 IN IN419DEN2012 patent/IN2012DN00419A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1313164A (en) * | 1969-04-28 | 1973-04-11 | Knox Gelatine Inc | Blood plasma substitute |
EP0223906A2 (de) * | 1982-10-29 | 1987-06-03 | Synthetic Blood Corporation | Gelatinbasierter vollständiger Blutersatz und dessen Herstellungsverfahren |
Non-Patent Citations (2)
Title |
---|
FELMUS ET AL: "Gelatin solution as a plasma substitute in the treatment of shock from acute blood loss", AMERICAN JOURNAL OF SURGERY, PAUL HOEBER, NEW YORK, NY, US, vol. 78, no. 3, 1 September 1949 (1949-09-01), pages 374 - 378, XP026414604, ISSN: 0002-9610, [retrieved on 19490901] * |
HABIF ET AL: "A balanced fluid gelatin for the treatment of hemorrhage", ANNALS OF SURGERY, vol. 173, no. 1, 1 January 1971 (1971-01-01), pages 85 - 90, XP002638063 * |
Also Published As
Publication number | Publication date |
---|---|
MX2012000957A (es) | 2012-03-06 |
WO2011009797A2 (de) | 2011-01-27 |
DE102009034132A1 (de) | 2011-01-27 |
KR20120046160A (ko) | 2012-05-09 |
EP2456446A2 (de) | 2012-05-30 |
BR112012001229A2 (pt) | 2016-03-01 |
CN102470147A (zh) | 2012-05-23 |
RU2012105925A (ru) | 2013-08-27 |
IN2012DN00419A (de) | 2015-05-15 |
DE202010018349U1 (de) | 2015-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213517A (en) | Sulfonamide derivatives, pharmaceuticals containing them and their use in the preparation of drugs | |
WO2011009759A3 (de) | Verwendung von dihydroquercetin und mindestens einer aminosäure zur positiven beeinflussung des natürlichen pigmentierungsprozesses | |
WO2008132229A3 (en) | Highly concentrated insulin solutions and compositions | |
WO2009024677A3 (fr) | Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses | |
WO2012088266A3 (en) | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2012075383A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2009130198A3 (en) | Hyperglycosylated human coagulation factor ix | |
IL213019A (en) | Derivatives 1-Azo-3-Terroyl-Azoline, Pharmaceutical Preparations Containing and Using Them | |
WO2012021715A3 (en) | Stable formulations of linaclotide | |
WO2009004629A3 (en) | A method for decreasing symptoms of alcohol consumption | |
WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
WO2011106423A3 (en) | Acai and iridoid based formulations | |
ECSP088745A (es) | Derivados sustituidos de cromanol y su uso | |
WO2011106417A3 (en) | Garcinia mangostana l. and iridoid based formulations | |
WO2012049307A3 (en) | Novel n-terminally modified insulin derivatives | |
WO2011106432A3 (en) | Morinda citrifolia and iridoid based formulations | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2012135619A3 (en) | Intranasal benzodiazepine pharmaceutical compositions | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
EP2386553A4 (de) | Benzimidazol-4-carboxamidderivate, ihr herstellungsverfahren, pharmazeutische zusammensetzungen und ihre verwendung | |
MX2012001691A (es) | Composiciones de linaclotida que se desintegran oralmente. | |
IN2012DN00239A (de) | ||
MX2012010127A (es) | Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos. | |
WO2011053265A3 (en) | The parmaceutical compositions comprising calcium and vitamin d |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080033076.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10734480 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010734480 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20127000796 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 419/DELNP/2012 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/000957 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012105925 Country of ref document: RU |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012001229 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012001229 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120118 |